Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes after elective total aortic arch replacement: Does obesity matter?

JTCVS open·2026
Same author

Implementation of a supervised outpatient residence to support ambulatory hematopoietic stem cell transplantation: experience from Puebla, México.

Bone marrow transplantation·2026
Same author

Ten-year outcomes of valve-replacing versus valve-sparing aortic root replacement in patients with Marfan syndrome: An observational multicenter study.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Long-term echocardiographic and clinical outcomes after aortic root replacement in patients with Marfan syndrome.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Late failure of endovascular aortic repair: Indications for and outcomes of endograft explantation.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Commentary: Valve-sparing procedures in Marfan syndrome: Progress, perspective, and priorities.

The Journal of thoracic and cardiovascular surgery·2026

Related Experiment Video

Updated: Sep 24, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.2K

miRNAs in multiple sclerosis: A clinical approach.

Claudia Minutti-Zanella1, Lorena Bojalil-Álvarez2, Elizabeth García-Villaseñor3

  • 1Universidad de las Américas Puebla, San Andrés Cholula, PUE, México; Centro de Hematología y Medicina Interna, Clínica RUIZ, PUE, Méixico.

Multiple Sclerosis and Related Disorders
|May 9, 2022
PubMed
Summary

Micro-RNAs (miRNAs) are key players in multiple sclerosis (MS), influencing its development and progression. Research highlights their potential as diagnostic biomarkers and therapeutic targets for this neurodegenerative autoimmune disease.

Keywords:
BiomarkersImmune modulationMultiple sclerosismiRNAs

More Related Videos

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
13:36

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

19.6K
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

4.2K

Related Experiment Videos

Last Updated: Sep 24, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.2K
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
13:36

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

19.6K
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

4.2K

Area of Science:

  • Biochemistry
  • Neuroimmunology
  • Molecular Biology

Background:

  • Multiple sclerosis (MS) is a progressive neurodegenerative autoimmune disease.
  • Micro-RNAs (miRNAs) are small noncoding RNA molecules involved in gene regulation.
  • miRNAs have emerged as critical mediators in the pathogenesis of MS.

Purpose of the Study:

  • To review the current understanding of micro-RNAs (miRNAs) in multiple sclerosis (MS).
  • To explore the role of miRNAs in MS etiology, molecular mechanisms, diagnosis, and treatment.
  • To assess the potential of miRNAs as biomarkers and therapeutic targets for MS.

Main Methods:

  • Literature review of recent findings on miRNAs and MS.
  • Analysis of studies investigating miRNA involvement in MS pathogenesis.
  • Synthesis of information regarding miRNA-based diagnostics, therapeutics, and prognostics.

Main Results:

  • miRNAs are implicated in the molecular mechanisms underlying MS development and progression.
  • Specific miRNAs show potential as diagnostic biomarkers for MS.
  • miRNAs represent promising targets for novel MS therapeutic strategies.
  • miRNA expression levels may predict disease prognosis in MS patients.

Conclusions:

  • Micro-RNAs (miRNAs) are significant molecular players in multiple sclerosis (MS).
  • miRNAs offer potential as diagnostic tools, therapeutic targets, and prognostic indicators for MS.
  • Further research into miRNAs could lead to improved management of multiple sclerosis.